Wantai BioPharm, founded in 1991, is a leading high-tech enterprise specializing in the research, development, and production of biological diagnostic tests and vaccines. Committed to our mission of "Advancing Human Health Through Biotechnology", we translate cutting-edge scientific innovations into reliable, high-quality healthcare solutions that benefit communities worldwide.

The company has seven subsidiaries, and its products cover a wide range of fields, including Total laboratory solution (TLA), biochemistry, chemiluminescence, Immunoassays, colloidal gold tests, molecular, bioactive materials, quality control products, and vaccines.

Our research leadership was formally recognized in 2005 when the Ministry of Science and Technology endorsed the establishment of the National Institute of Diagnostics and Vaccine Development (NIDVD) - a landmark collaboration between Xiamen University and Yangshengtang Group, Wantai BioPharm's parent company.

This premier research center functions as both an industrial incubator and innovation accelerator, driving cutting-edge R&D with global impact.